![](/img/cover-not-exists.png)
PCN74 COST-EFFECTIVENESS OF NEXT-GENERATION SEQUENCING MINIMAL RESIDUAL DISEASE TESTING PRIOR TO STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA
Zimmermann, M., Eckert, B., Carlson, J.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.198
Date:
May, 2019
File:
PDF, 382 KB
2019